Free Trial

Schrodinger (SDGR) Competitors

Schrodinger logo
$22.49 -0.54 (-2.34%)
Closing price 04:00 PM Eastern
Extended Trading
$22.92 +0.44 (+1.93%)
As of 04:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SDGR vs. TGTX, NUVL, LNTH, RYTM, AXSM, TLX, CRSP, PCVX, CYTK, and MTSR

Should you be buying Schrodinger stock or one of its competitors? The main competitors of Schrodinger include TG Therapeutics (TGTX), Nuvalent (NUVL), Lantheus (LNTH), Rhythm Pharmaceuticals (RYTM), Axsome Therapeutics (AXSM), Telix Pharmaceuticals (TLX), CRISPR Therapeutics (CRSP), Vaxcyte (PCVX), Cytokinetics (CYTK), and Metsera (MTSR). These companies are all part of the "pharmaceutical products" industry.

Schrodinger vs. Its Competitors

Schrodinger (NASDAQ:SDGR) and TG Therapeutics (NASDAQ:TGTX) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, analyst recommendations, media sentiment, dividends, profitability and risk.

TG Therapeutics has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than TG Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Schrodinger$207.54M7.95-$187.12M-$2.63-8.55
TG Therapeutics$329M17.63$23.38M$0.24152.21

TG Therapeutics has a net margin of 10.13% compared to Schrodinger's net margin of -83.39%. TG Therapeutics' return on equity of 18.88% beat Schrodinger's return on equity.

Company Net Margins Return on Equity Return on Assets
Schrodinger-83.39% -44.74% -26.29%
TG Therapeutics 10.13%18.88%7.05%

Schrodinger currently has a consensus price target of $32.75, suggesting a potential upside of 45.62%. TG Therapeutics has a consensus price target of $43.80, suggesting a potential upside of 19.90%. Given Schrodinger's higher possible upside, research analysts clearly believe Schrodinger is more favorable than TG Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Schrodinger
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75
TG Therapeutics
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

79.1% of Schrodinger shares are held by institutional investors. Comparatively, 58.6% of TG Therapeutics shares are held by institutional investors. 8.6% of Schrodinger shares are held by company insiders. Comparatively, 10.6% of TG Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Schrodinger has a beta of 1.58, indicating that its stock price is 58% more volatile than the S&P 500. Comparatively, TG Therapeutics has a beta of 1.91, indicating that its stock price is 91% more volatile than the S&P 500.

In the previous week, Schrodinger and Schrodinger both had 5 articles in the media. TG Therapeutics' average media sentiment score of 1.67 beat Schrodinger's score of 0.56 indicating that TG Therapeutics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Schrodinger
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
TG Therapeutics
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

TG Therapeutics beats Schrodinger on 13 of the 15 factors compared between the two stocks.

Get Schrodinger News Delivered to You Automatically

Sign up to receive the latest news and ratings for SDGR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SDGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SDGR vs. The Competition

MetricSchrodingerMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.65B$2.11B$5.67B$9.50B
Dividend YieldN/AN/A4.05%4.00%
P/E Ratio-8.5537.0527.9219.98
Price / Sales7.9515.60397.1882.73
Price / CashN/A54.1536.1958.45
Price / Book3.899.028.635.82
Net Income-$187.12M-$63.59M$3.24B$258.42M
7 Day Performance3.88%3.01%3.17%1.94%
1 Month Performance9.17%12.14%10.73%12.08%
1 Year Performance2.98%9.69%35.04%20.90%

Schrodinger Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SDGR
Schrodinger
2.091 of 5 stars
$22.49
-2.3%
$32.75
+45.6%
+1.6%$1.65B$207.54M-8.55790Upcoming Earnings
TGTX
TG Therapeutics
3.729 of 5 stars
$38.92
+5.0%
$43.80
+12.5%
+85.5%$6.18B$329M162.17290Positive News
NUVL
Nuvalent
3.3182 of 5 stars
$84.59
+4.5%
$119.60
+41.4%
-2.5%$6.07BN/A-19.2740Analyst Forecast
LNTH
Lantheus
4.7082 of 5 stars
$83.06
+2.2%
$131.20
+58.0%
-36.5%$5.75B$1.53B23.60700Positive News
Upcoming Earnings
RYTM
Rhythm Pharmaceuticals
3.1406 of 5 stars
$89.15
+2.8%
$91.00
+2.1%
+76.3%$5.67B$130.13M-31.73140
AXSM
Axsome Therapeutics
4.7254 of 5 stars
$112.33
+3.1%
$172.33
+53.4%
+24.2%$5.53B$385.69M-19.47380Analyst Revision
TLX
Telix Pharmaceuticals
N/A$15.57
-2.5%
$22.33
+43.4%
N/A$5.27B$783.21M0.00N/ATrending News
Analyst Revision
CRSP
CRISPR Therapeutics
1.7435 of 5 stars
$56.42
-0.7%
$71.75
+27.2%
+19.1%$4.87B$37.31M-12.48460Analyst Forecast
Analyst Revision
PCVX
Vaxcyte
1.892 of 5 stars
$36.38
+1.3%
$136.50
+275.2%
-56.6%$4.69BN/A-9.12160Positive News
CYTK
Cytokinetics
4.2357 of 5 stars
$38.58
+4.2%
$70.92
+83.8%
-33.9%$4.61B$18.47M-7.29250
MTSR
Metsera
N/A$42.47
+8.1%
$55.00
+29.5%
N/A$4.46BN/A0.0081Gap Down

Related Companies and Tools


This page (NASDAQ:SDGR) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners